Want to Participate in Cutting-Edge Brain Research?
Contact us today for eligibility screening and consultation.
NoahTech is proud to support this pre-IND randomized, double-blind, placebo-controlled study investigating a novel cognitive enhancement intervention for adults with early signs of cognitive decline.
Currently Recruiting
Advancing the future of brain health through rigorous, ethical, and innovative clinical research.
This pre-IND clinical trial (NCT07214974) evaluates the safety and efficacy of a novel non-invasive cognitive enhancement protocol in adults aged 55–75 with mild cognitive impairment (MCI) or early age-related cognitive decline. NoahTech provides certified MoCA administration, standardized cognitive assessments, and data management support.
Conditions: Mild Cognitive Impairment, Age-Related Cognitive Decline
Intervention: Novel Cognitive Enhancement Protocol vs Placebo
Design: Randomized, Double-Blind, Placebo-Controlled, Parallel Assignment
Change in Montreal Cognitive Assessment (MoCA) score from baseline to Week 12.
Secondary outcomes include executive function, memory performance, and safety/tolerability.
To learn more or check eligibility, visit the official listing: https://clinicaltrials.gov/study/NCT07214974
Or contact our team directly: info@noahtech.life